Wall Street Breakfast cover image

Novartis puts $12B on the table

Wall Street Breakfast

00:00

Novartis Agrees to Buy Avidity for $12B

Julie Morgan reports Novartis' $72-per-share offer for Avidity Biosciences and market reactions, including analyst commentary and related RNA winners.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app